IMA
ImageneBio, Inc.
NASDAQ: IMA · HEALTHCARE · BIOTECHNOLOGY
$6.02
+1.52% today
Updated 2026-04-30
Market cap
$65.21M
P/E ratio
—
P/S ratio
81.51x
EPS (TTM)
$-9.64
Dividend yield
—
52W range
$4 – $18
Volume
0.4M
ImageneBio, Inc. (IMA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-83.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-208.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.3%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $-0.62 | +46.3% | $5.92 | $6.01 | +1.5% |
| 2025-11-12 | $-2.91 | -191.0% | $8.61 | $8.33 | -3.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.15 | $-0.62 | +46.3% | — | — |
| 2025-09-30 | $-1.00 | $-2.91 | -191.0% | — | — |
| 2025-06-30 | $-0.14 | $-0.69 | -386.9% | — | — |
| 2025-03-31 | $-0.19 | $-0.17 | +11.4% | — | — |
| 2024-12-31 | $-0.21 | $-0.20 | +3.2% | — | — |
| 2024-09-30 | $-0.25 | $-0.21 | +17.6% | $3.50M | +195.4% |
| 2024-06-30 | $-0.36 | $-0.28 | +22.2% | — | — |
| 2024-03-31 | $-0.33 | $-0.33 | +0.0% | — | — |
| 2023-12-31 | $-0.41 | $-0.41 | +0.0% | $659000.00 | — |
| 2023-09-30 | $-0.40 | $-0.40 | +0.0% | $1.19M | — |
| 2023-06-30 | $-0.44 | $-0.44 | +0.0% | $2.00M | — |
| 2023-03-31 | $-0.39 | $-0.39 | +0.0% | $5.31M | — |
Frequently asked questions
Has ImageneBio, Inc. beaten earnings estimates?
ImageneBio, Inc. has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -83.3% over the last 4 quarters.
How does IMA stock react to earnings?
IMA stock has moved an average of -0.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.